Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Neurofilaments as biomarkers in multiple sclerosis.
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
[Optic neuropathy and meningioma: A diagnostic trap.]
Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Modifiable Comorbidities and Disability in Multiple Sclerosis.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.

Pages